New Study Shows High-Dose Wegovy Injections Achieve 28% Weight Loss
Novo Nordisk has announced new study results confirming that high-dose Wegovy injections help patients lose nearly 28% of their weight over 72 weeks. This announcement follows the launch of the new dosage in the United States just a month ago.